The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
97864999 9786499 9 F 20070605 20160726 20131227 20160729 EXP US-009507513-1312USA009131 MERCK 0.00 F Y 70.75000 KG 20160729 LW US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
97864999 9786499 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW 15540.48 MG 20560 70 MG TABLET /wk
97864999 9786499 2 SS FOSAMAX PLUS D ALENDRONATE SODIUMCHOLECALCIFEROL 1 Oral 70 MG/2800 MG, QW 70 MG 0 70 MG TABLET /wk
97864999 9786499 3 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 3150 MG U 0 70 MG /wk
97864999 9786499 4 SS ZOMETA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) 4 MG, ONCE A YEAR U 0 4 MG /yr
97864999 9786499 5 C VITAMINS (UNSPECIFIED) VITAMINS 1 Unknown 1 DF, QD U 0 1 DF QD
97864999 9786499 6 C CHOLECALCIFEROL CHOLECALCIFEROL 1 Unknown 5000 IU, QD U 0 5000 IU QD
97864999 9786499 7 C IRON (UNSPECIFIED) IRON 1 Unknown 55 MG, QD U 0 55 MG QD
97864999 9786499 8 C ASCORBIC ACID. ASCORBIC ACID 1 Unknown 500 MG, QD U 0 500 MG QD
97864999 9786499 9 C XANTHOPHYLL 2 Unknown 20 MG, QD U 0 20 MG QD
97864999 9786499 10 C ASPIRIN. ASPIRIN 1 Unknown 31 MG, QD U 0 31 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
97864999 9786499 1 Osteoporosis
97864999 9786499 3 Osteoporosis
97864999 9786499 4 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
97864999 9786499 OT
97864999 9786499 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
97864999 9786499 Anaemia postoperative
97864999 9786499 Aortic valve sclerosis
97864999 9786499 Arteriosclerosis coronary artery
97864999 9786499 Breast cancer female
97864999 9786499 Cataract
97864999 9786499 Chronic obstructive pulmonary disease
97864999 9786499 Clavicle fracture
97864999 9786499 Constipation
97864999 9786499 Fall
97864999 9786499 Femur fracture
97864999 9786499 Hyperlipidaemia
97864999 9786499 Hypothyroidism
97864999 9786499 Metastases to bone
97864999 9786499 Nasopharyngitis
97864999 9786499 Osteoarthritis
97864999 9786499 Osteoporosis
97864999 9786499 Rib fracture
97864999 9786499 Stress cardiomyopathy
97864999 9786499 Upper limb fracture
97864999 9786499 Urge incontinence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
97864999 9786499 1 20070316 20070416 0
97864999 9786499 2 20081031 0
97864999 9786499 3 20080527 20090330 0
97864999 9786499 4 2009 2011 0
97864999 9786499 5 2004 0
97864999 9786499 6 1994 0
97864999 9786499 7 2004 0
97864999 9786499 8 2004 0
97864999 9786499 9 2004 0
97864999 9786499 10 1993 0